Citigroup
IH

Citigroup’s iHuman IH Stock Holding History

Citigroup’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-760
Closed -$8K – 6035
2021
Q2 		$8K Sell
760
-1,055
-58% -$11.6K ﹤0.01% 5738
2021
Q1 		$23K Buy
+1,815
New +$32K ﹤0.01% 5166

Other funds holding IH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup's IH Position: Q3 2021 in Review

Citigroup sold out of iHuman (IH) in Q3 2021, closing a stake of 760 shares — an estimated $8K sold.

Citigroup first reported a position in IH in Q1 2021 and held it in 2 quarters. The position peaked at $23K in Q1 2021. 10 funds tracked by Wall St. Rank hold IH as of Q3 2021.

  • Citigroup reported no remaining iHuman position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 760 iHuman shares in Q3 2021, an estimated $8K.
  • Citigroup first reported a position in iHuman in Q1 2021 and held it in 2 quarters.
  • Citigroup's iHuman position peaked at $23K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held iHuman as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.